XML 84 R71.htm IDEA: XBRL DOCUMENT v3.22.2
Income taxes (Tables)
12 Months Ended
Mar. 31, 2022
Disclosure of income tax [Abstract]  
Disclosure of income tax [Table Text Block]
Income tax expense/(benefit) recognized in the consolidated income statement consists of the following:
 
 
 
For the Year Ended March 31,
 
 
 
2022
 
 
2021
 
 
2020
 
Current taxes
            
Domestic Rs.
4,180
  Rs.
5,849
  
Rs.
5,157 
Foreign  2,231   2,323   1,459 
 
 
Rs.
6,411
 
 
Rs.
8,172
 
 
Rs.
6,616
 
Deferred taxes
            
Domestic Rs.
2,165
  Rs.
2,736
  
Rs.
(6,580) 
Foreign  154   (1,733)  (1,502)
 
 
Rs.
2,319
 
 
Rs.
1,003
 
 
Rs.
(8,082)
 
Tax expense/(benefit), net
 
Rs.
8,730
 
 
Rs.
9,175
 
 
Rs.
(1,466)
 
Current and deferred tax relating to items charged or credited directly to equity [Table Text Block]
Income tax expense/(benefit) recognized directly in equity consists of the following:
 
 
 
For the Year Ended March 31,
 
 
 
2022
 
 
2021
 
 
2020
 
Tax effect on changes in fair value of other investments Rs.(293) Rs.293  Rs.- 
Tax effect on effective portion of change in fair value of cash flow hedges  288   319   (232)
Tax effect on actuarial gains/losses on defined benefit obligations  (12)  (73)  22 
 
 
Rs.
(17
)
 
Rs.
539
 
 
Rs.
(210
)
Reconciliation Between Enacted and Effective Tax Rates [Table Text Block]
The following is a reconciliation of the Company’s effective tax rates for the years ended March 31, 2022, 2021 and 2020:
 
 
 
For the Year Ended March 31,
 
 
 
2022
 
 
2021
 
 
2020
 
Profit before income taxes
 
Rs.
32,298
 
 
Rs.
26,413
 
 
Rs.
18,032
 
Enacted tax rate in India  34.94%  34.94%  34.94%
Computed expected tax expense
 
Rs.
11,285
 
 
Rs.
9,229
 
 
Rs.
6,301
 
Effect of:
            
Differences between Indian and foreign tax rates Rs.(427) Rs.810  Rs.3,385 
Unrecognized deferred tax assets/(recognition of previously unrecognized deferred tax assets, net)  97   1,220   (6,478)
Expenses not deductible for tax purposes  208   230   155 
Income exempt from income taxes  (1,619)  (1,807)  (1,029)
Foreign exchange differences  (55)  (18)  (64)
Incremental deduction allowed for research and development costs
(1)
  -   -   (1,241)
Tax expense on distributed/undistributed earnings of subsidiary outside India  (220)  -   254 
Income from sale of capital assets  (305)  -   (2,620)
Effect of change in tax rate  -   (333)  (37)
Others  (234)  (156)  (92)
Income tax expense/(benefit)
 
Rs.
8,730
 
 
Rs.
9,175
 
 
Rs.
(1,466
)
Effective tax rate
 
 
27
%
 
 
35
%
 
 
(8
)%
 
(1)
India’s Finance Act, 2016 incorporated an amendment that reduces the weighted deduction on eligible research and development expenditure in a phased manner from 200% to 150% commencing from April 1, 2017 and from 150% to 100% effective April 1, 2020.
Disclosure of Unrecognised Deferred Tax Assets and Liabilities [Table Text Block]
The details of unrecognized deferred tax assets are summarized below:
 
 
 
As of March 31,
 
 
 
2022
 
 
2021
 
Deductible temporary differences, net  
Rs.
538    
Rs.
738  
Operating tax loss carry-forward     4,590       4,742  
 
 
Rs.
5,128
 
 
Rs.
5,480
 
Disclosure of Tax Effects of Significant Temporary Differences That Resulted In Deferred Tax [Table Text Block]
The tax effects of significant temporary differences that resulted in deferred tax assets and liabilities and a description of the items that created these differences is given below:
 
 
 
As of March 31,
 
 
 
2022
 
 
2021
 
Deferred tax assets/(liabilities):
               
Inventory  
Rs.
3,197    
Rs.
3,997  
Minimum Alternate Tax*     3,929       4,748  
Trade and other receivables**     710       569  
Operating/other tax loss carry-forward     2,053       2,593  
Other current assets and other current liabilities, net     1,546       1,404  
Property, plant and equipment     (3,300 )     (2,547 )
Other intangible assets     34       (283 )
Others     (25 )     (189 )
Net deferred tax assets
 
Rs.
8,144
 
 
Rs.
10,292
 
 
*
As per Indian tax laws, companies are liable for a Minimum Alternate Tax (“MAT”) when current tax, as computed under the provisions of the Income Tax Act, 1961 (“Tax Act”), is determined to be below the MAT computed under section 115JB of the Tax Act. If in any year the Company pays a MAT, then it is entitled to claim credit of the MAT paid over and above the normal tax liability in the subsequent years. The MAT credit is eligible to be carried forward and set-off in the future against the current tax liabilities over a period of 15 years starting from the succeeding fiscal year in which such credit was generated.

**
The final regulations addressing changes in income recognition rules under Treas. Reg. sections 1.451-3 and 1.451-8 were published on January 6, 2021, and are effective for tax years beginning on or after January 1, 2021.  The final regulations which are mandatory for tax years beginning after December 31, 2020, are consistent with the Internal Revenue Service’s (IRS) position and therefore create the need for the Company to change its current accounting method used for chargebacks to align with the final regulations.   As a consequence, of the new regulations, Dr. Reddy’s Laboratories Inc. U.S.A. has created a deferred tax asset and deferred tax liability in the financial statements reported for the year ending March 31, 2022.
Disclosure Of Movement in deferred tax assets and liabilities [Table Text Block]
 
   
As of March
31, 2021
   
Recognized in
income
statement
   
Recognized in
equity
   
As of March
31, 2022
 
Deferred tax assets/(liabilities):
                               
Inventory  
Rs.
3,997    
Rs.
(800 )  
Rs.
-    
Rs.
3,197  
Minimum Alternate Tax     4,748       (819 )
 
 
-
 
    3,929  
Trade and other receivables     569       141       -       710  
Operating/other tax loss carry-forward     2,593       (540 )
 
 
-
 
    2,053  
Other current assets and other current liabilities, net     1,404       142       -       1,546  
Property, plant and equipment     (2,548 )     (752 )
 
 
-
 
    (3,300 )
Other intangible assets     (283 )     317
 
 
-
 
    34  
Others     (188 )     146       17       (25 )
Net deferred tax assets
 
Rs.
10,292
 
 
Rs.
(2,165
)
 
 
Rs.
17
 
 
Rs.
8,144
 
 
The details of movement in deferred tax assets and liabilities are summarized below:
 
   
As of March
31, 2020
   
Recognized in
income
statement
   
Recognized in
equity
   
As of March
31, 2021
 
Deferred tax assets/(liabilities):
                               
Inventory  
Rs.
3,216    
Rs.
781    
Rs.
-    
Rs.
3,997  
Minimum Alternate Tax     6,246       (1,498 )
 
 
-
 
    4,748  
Trade and other receivables     369       200       -       569  
Operating/other tax loss carry-forward     3,399       (806 )
 
 
-
 
    2,593  
Other current assets and other current liabilities, net     1,448      
(44
    -       1,404  
Property, plant and equipment     (2,361 )     (187 )
 
 
-
 
    (2,548 )
Other intangible assets     (477 )     194  
 
 
-
 
    (283 )
Others     99       252       (539 )     (188 )
Net deferred tax assets
 
Rs.
11,939
 
 
Rs.
(1,108
)
 
Rs.
(539
)
 
Rs.
10,292